Tuesday, October 11, 2011
Maxygen, Inc. brought an inter partes re-examination of Amgen's U.S. Pat. No. 7,381,804 in 2009 . There has now been a final rejection of claims.
Intellectual property news affecting business and everyday life
0 Comments:
Post a Comment
<< Home